Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IBRX
IBRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IBRX News
ImmunityBio Receives FDA Review for ANKTIVA Application
2d ago
Yahoo Finance
GT Biopharma: Three Drugs Enter Human Trials
1d ago
PRnewswire
GT Biopharma Advances Three Drug Candidates in Clinical Trials
1d ago
Newsfilter
Multiple Companies Face Class Action Lawsuits
4d ago
Globenewswire
ImmunityBio Faces Securities Class Action Lawsuit
4d ago
PRnewswire
Reminder for ImmunityBio Securities Class Action
4d ago
Globenewswire
ImmunityBio Faces Securities Class Action Lawsuit Over Misleading Claims
5d ago
Globenewswire
ImmunityBio Faces Class Action Lawsuit Reminder
5d ago
Globenewswire
ImmunityBio Faces Class Action Lawsuit for Securities Violations
6d ago
Globenewswire
Reminder of ImmunityBio Securities Class Action
6d ago
PRnewswire
ImmunityBio Faces Securities Class Action Lawsuit
May 23 2026
PRnewswire
Reminder of ImmunityBio Securities Class Action
May 22 2026
Globenewswire
ImmunityBio Faces Class Action Lawsuit
May 22 2026
Globenewswire
Lowey Dannenberg Investigates ImmunityBio for Potential Securities Violations
May 22 2026
Globenewswire
Securities Fraud Class Action Filed Against ImmunityBio, Inc.
May 22 2026
PRnewswire
ImmunityBio Faces Securities Class Action Lawsuit Over Misleading Claims
May 22 2026
Globenewswire
Show More News
